Dr. Richard M. Weinshilboum will initiate the 2012 NICHD Director’s Lecture Series with a lecture on Pharmacogenomics: Beyond Biomarkers. Dr. Weinshilboum is the Mary Lou and John H. Dasburg Professor for Cancer Genomics Research, the chair of the Division of Clinical Pharmacology, and a professor of Molecular Pharmacology and Experimental Therapeutics and Medicine at the Mayo Clinic in Rochester, Minnesota. He is also a principal investigator on several NIH grants, including a clinical pharmacology training grant that receives support from the NICHD. Dr. Weinshilboum’s research has focused on drugs used to treat breast cancer and on medications for depression.
Pharmacogenomics is the study of the role of genetic inheritance as it influences individual variability in drug responses. For example, just as genetic makeup varies from individual to individual, so too can the response to a drug vary from mild loss of drug efficacy in one individual to severe adverse reaction in another.
During this lecture, Dr. Weinshilboum will discuss these topics:
Specifics of the event are as follows:
The NICHD Director’s Lecture Series is open to the public, and registration is not required. Non-NIH employees should visit http://www.nih.gov/about/visitor/index.htm for details about getting to the NIH campus and security procedures.
Individuals with disabilities who need sign language interpreters and/or reasonable accommodations to participate should contact Vernon Cardwell (firstname.lastname@example.org or 301-594-1968) or the Federal TTY Relay Number (1-800-877-8339). Please make your requests at least five days in advance of the event.
For more information, select one of the links below:
Originally posted: January 10, 2012
All NICHD Spotlights
All related topics
All related organizational units